KALA BIO, Inc.
KALA
$3.75
$0.030.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.74% | 16.06% | -348.22% | -50.18% | 5.85% |
| Total Depreciation and Amortization | -14.52% | -16.93% | -28.31% | -36.11% | -43.58% |
| Total Amortization of Deferred Charges | -0.40% | 2.02% | 5.23% | -6.51% | -12.07% |
| Total Other Non-Cash Items | 146.04% | 214.02% | 110.65% | 109.56% | 110.46% |
| Change in Net Operating Assets | -120.00% | -164.49% | 177.51% | 264.15% | 1,711.61% |
| Cash from Operations | -5.21% | 4.37% | 34.22% | 54.91% | 64.61% |
| Capital Expenditure | 65.90% | 76.64% | 11.78% | -51.47% | -94.89% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -58.77% | -58.77% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 227.13% | -97.32% | 1,575.00% |
| Cash from Investing | 51.52% | 60.65% | -82.37% | -100.49% | -100.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 49.55% | 99.82% | 100.00% | 100.00% | 75.02% |
| Issuance of Common Stock | 43.49% | -68.76% | -68.74% | -92.09% | -42.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 334.50% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 94.17% | 94.17% | 94.17% | 94.17% | -- |
| Cash from Financing | 251.23% | -31.76% | 1,305.80% | 368.96% | 207.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.44% | -300.61% | -17.47% | -644.68% | 17.75% |